| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 01/29/2004 | WO2003040080A3 Lipoxin a4 analogs |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019190 Thrombopoietin mimetics |
| 01/29/2004 | US20040019110 Lipoxin analogs and method for the treatment of periodontal disease |
| 01/29/2004 | US20040019087 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | US20040019043 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | CA2493127A1 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | CA2492907A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/28/2004 | EP1383799A1 Probes, systems and methods for drug discovery |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | EP1383730A2 Anticholinergic compounds and methods of use |
| 01/28/2004 | CN1470502A Method for purifying amino acetic acid by electrodialytic separation |
| 01/28/2004 | CN1136193C Imide derivatives ar Salts thereof |
| 01/27/2004 | US6683213 Chemical intermediates for pyridinedicarboxamide herbicides |
| 01/27/2004 | US6683208 For use in preparation of optically active carboxylic acids and/or derivatives |
| 01/27/2004 | US6683190 Contacting racemic hydantoin with enantiomeric splitting agent; decyclization |
| 01/27/2004 | US6683112 Gabapentin prodrugs and formulations |
| 01/27/2004 | US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/27/2004 | CA2061007C Zirconium/aluminum antiperspirant material and antiperspirant compositions containing same |
| 01/22/2004 | WO2004007439A1 Biaryl derivatives |
| 01/22/2004 | WO2004007428A1 Process for the preparation of phenylalanine enamide derivatives |
| 01/22/2004 | WO2003049690A3 Hiv integrase inhibitors |
| 01/22/2004 | US20040014984 Amination by reducing the nitro group on pyrrole ring, amidation with a blocking group on the 4-amino group; useful as peptide, use in nucleotide sequence recognition |
| 01/22/2004 | US20040014837 Dimethylamine (DMA) and at least one optionally substituted alpha , beta unsaturated ester obtained or obtainable by reacting a suitable acrylic or methacrylic acid with a suitable alcohol or polyol, chartacterised that said adduct |
| 01/22/2004 | CA2492441A1 Process for the preparation of phenylalanine enamide derivatives |
| 01/21/2004 | EP1382595A1 Fixed bed copper Raney catalyst for dehydrogenating alcohols |
| 01/21/2004 | EP1382591A1 Novel atisane compound and use thereof |
| 01/21/2004 | EP1382390A1 Copper Raney catalyst for the dehydrogenation of alcohols |
| 01/21/2004 | EP1382389A1 Raney copper catalyst for the dehydrogenation of alcohols |
| 01/21/2004 | EP1382388A1 Fixed-bed copper Raney catalyst for dehydrating alcohols |
| 01/21/2004 | EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria |
| 01/21/2004 | EP1381597A2 Processes and intermediates for preparing benzyl substituted epoxides |
| 01/21/2004 | EP1254092B1 Resolution of dl-racemic mixtures |
| 01/21/2004 | EP1140794B1 Novel method for preparing chiral amino acids |
| 01/21/2004 | EP1100774B1 Improved arylamine synthesis |
| 01/21/2004 | CN1468603A Prepn of potassium magnesium aspartate for injection |
| 01/20/2004 | US6680345 Salicylic acid salts of salmeterol |
| 01/20/2004 | US6679663 Locking nut, bolt and clip systems and assemblies |
| 01/15/2004 | WO2004004648A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/15/2004 | WO2003062191A8 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 01/15/2004 | US20040010149 Ligand for transition metal complex catalyst |
| 01/15/2004 | CA2491127A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/14/2004 | EP1379494A1 Fused bicyclic or tricyclic amino acids |
| 01/14/2004 | EP1174418B1 Process for the preparation of anhydrous, pharmaceutical grade gabapentin |
| 01/14/2004 | CN1468209A Stable salts of o-acetylsalicyclic with basic amino acids |
| 01/14/2004 | CN1468207A New retinoids for the treatment of emphysema |
| 01/14/2004 | CN1467200A Monozinc-calcium di-L-Aspartate |
| 01/14/2004 | CN1467199A Monozinc di-L-lysine |
| 01/14/2004 | CN1467198A Monozinc di-L-Aspartate |
| 01/13/2004 | US6677476 Process for preparing R-(-) -carnitine from S-(-)-chlorosuccinic acid or from a derivative thereof |
| 01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |
| 01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
| 01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/08/2004 | WO2004003331A2 Non-corrosive amphoteric surfactants and method of well treatment |
| 01/08/2004 | WO2004002944A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002940A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002939A2 Aminoalcohol derivatives |
| 01/08/2004 | WO2004002938A1 Process for recovering betaine |
| 01/08/2004 | US20040006247 Reacting isobutylene, ethylene and mineral acid; hydrolyzing the ester to produce 3,3-dimethylbutanol; and converting 3,3-dimethylbutanol to 3,3-dimethylbutanal |
| 01/08/2004 | US20040006245 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain |
| 01/08/2004 | US20040006225 Diastereomeric compound being subjected to a non-reductive removal of the residual fragment of the chiral auxiliary, the carbon atom that is removed having an oxidation state of +3 which is not lowered |
| 01/08/2004 | US20040006224 Synthesis of 2-alkyl amino acids |
| 01/08/2004 | US20040006222 Process for recovering betaine |
| 01/08/2004 | US20040006143 Aminoalcohol derivatives |
| 01/08/2004 | US20040006130 For therapy of osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia, autosomal dominant hypocalcemia |
| 01/08/2004 | US20040005637 Intermediate products coupled to solid polymeric support suitable for synthesis of heterocyclic compounds in simple and fast methods on solid phase; for synthesis of heterocycles with large structural diversity in high yields |
| 01/08/2004 | US20040005255 Appartus and process used in growing crystals |
| 01/08/2004 | CA2492065A1 Aminoalcohol derivatives_as b3 adrenergic receptor agonist |
| 01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490363A1 Non-corrosive amphoteric surfactants and method of well treatment |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/06/2004 | US6673942 Resolution of DL-racemic mixtures |
| 01/06/2004 | US6673837 Acetyl L-carnitine salt with a dicarboxylic organic acid and process for preparing same |
| 01/06/2004 | US6673832 Determining whether a compound alleviates vasoconstriction-independent nerve pain mediated by endothelin-1 |
| 01/06/2004 | US6673794 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 01/03/2004 | WO2004046085A1 Process for the preparation of amino methyl cyclo alkane acetic acids |
| 01/02/2004 | EP1375562A1 Diaminobenzene derivatives, polyimide precursors and polyimides prepared by using tha same, and liquid crystal aligning agents |
| 01/02/2004 | EP1373268A2 Method for the manufacture of anagrelide |
| 01/02/2004 | EP1373195A2 Quaternary amino acids on solid supports |
| 01/02/2004 | EP1373188A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 01/02/2004 | EP1373186A1 A process for the preparation of cyclic amino acids |
| 01/02/2004 | EP1372632A1 Proliferative activator receptor (ppar) compounds |
| 01/02/2004 | EP1372390A2 Alkylamine derivatives as antifouling agents |
| 01/01/2004 | US20040002613 Synthesis of benzonitriles from substituted benzoic acid |
| 01/01/2004 | US20040002605 Reacting 1,4-dialkylcarboxylate-2,5-bis(N-arylamino)benzene with iodoaryl compound |
| 01/01/2004 | US20040002480 Aminobutyric acid derivatives and pharmaceutical composition containing the same as active ingredient |
| 12/31/2003 | WO2004000786A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 12/31/2003 | WO2004000784A1 Preparation of protected amino acids |
| 12/31/2003 | WO2004000783A1 Aminoalkylphenols, methods of using and making the same |
| 12/31/2003 | WO2004000302A1 Novel resveratrol analogs |
| 12/31/2003 | WO2003078358A3 Use of microfabricated devices for radiosynthesis |
| 12/31/2003 | WO2003059915A3 ENANTIOSELECTIVE METHODS FOR PREPARING α- AND β-AMINO ACID DERIVATIVES |
| 12/30/2003 | US6670520 Water pollution control |
| 12/30/2003 | US6670494 Reacting organic acid with metal compound in nonaqueous solvent; simple; low energy; no waste products; environ-mentally safe |
| 12/30/2003 | US6670376 Aryl aniline β2 adrenergic receptor agonists |
| 12/30/2003 | US6670344 Having greater solubility than native combretastatin A-4, and rapidly regenerate combretastatin A-4 under physiological conditions; for use in cancer therapy |
| 12/30/2003 | US6670332 Cytofectins comprising complex amphiphilic lipids in which a bioactive agent which is recognized by biological systems is joined to a Rosenthal Inhibitor core structure through an alkyl linking group |